Preferred Label : cangrelor;
MeSH note : platelet P(2T) receptor antagonist; structure in first source;
CISMeF synonym : AR C69931MX;
MeSH synonym : N(6)-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-5'-adenylic acid monoanhydride
with dichloromethylenebis(phosphonic acid);
MeSH hyponym : AR-C69931MX;
MeSH Related Number : 2144G00Y7W;
Is substance : O;
UNII : 6AQ1Y404U7;
InChIKey : PAEBIVWUMLRPSK-IDTAVKCVSA-N;
Origin ID : C117446;
UMLS CUI : C1121991;
ATC code(s)
CISMeF manual mappings
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
http://www.has-sante.fr/portail/jcms/c_2620141/fr/kengrexal
2016
false
false
false
France
French
treatment outcome
cangrelor
cangrelor
drug therapy, combination
adult
coronary artery disease
percutaneous coronary intervention
injections, intravenous
infusions, intravenous
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
myocardial infarction
embolism and thrombosis
aspirin
hemorrhage
cangrelor
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
receptors, purinergic P2Y12
evaluation of the transparency committee
Cangrelor Tetrasodium
Cangrelor Tetrasodium
angioplasty
emergency treatment
adenosine monophosphate
---
https://www.ema.europa.eu/medicines/human/EPAR/Kengrexal
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
cangrelor
cangrelor
cangrelor
drug therapy, combination
adult
coronary artery disease
percutaneous coronary intervention
injections, intravenous
infusions, intravenous
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
platelet aggregation inhibitors
myocardial infarction
embolism and thrombosis
product surveillance, postmarketing
aspirin
hemorrhage
cangrelor
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
drug interactions
pregnancy
breast feeding
receptors, purinergic P2Y12
drug evaluation, preclinical
adenosine monophosphate
---